Powders · Contract manufacturing in India

Fosfomycin Trometamol 3 gm · Powder

Request a quote from Walter Healthcare for third-party manufacturing of Fosfomycin Trometamol 3 gm powder in India. Discuss pack sizes, minimum orders and lead times.

Catalogue reference
WH-1770
Composition and strength
Fosfomycin Trometamol 3 gm
Dosage form
Powder
Indicative administration route
Confirm for this presentation
Therapeutic navigation area
Anti-infectives
Pharmacological class
Antimicrobial agent
Manufacturing stream
Non-beta-lactam

How we pack and manufacture this product

Our pack history

10 × 1 × 10 g pack

We’ve accepted this sachet presentation. The 3 g figure is the formulation strength and 10 g is the sachet fill. We’ll quote the sachet and outer pack for your order quantity.

Manufacturing for your brand

Powder

Send us your net fill, jar count and scoop requirements. We’ll confirm the unit for your formulation and quote the complete retail pack.

Review our manufacturing documents

We confirm the manufacturing site and commercial terms for your order at quotation.

Quality systems aligned with

GMPWHO-GMP Certified PlantsWHO-GDP compliantRevised Schedule MGLP · Schedule L-1FSSAIFacility-scoped evidence

Editorial development perspective

What deserves attention in this formulation.

These notes use the catalogue composition and presentation to frame a technical discussion. They are planning considerations, not tested properties or clinical findings for this product.

A matching clinical reference has not yet been verified for this page. Drug-specific mechanisms and human pharmacokinetic values remain open for review.

About these development notes and source limitations ↗

Specify the powder’s intended preparation

Listed presentation: Powder.

Establish whether the powder is supplied for direct use, dispersion, dissolution or another defined preparation. Review blend consistency, flow, moisture control and the proposed measure or unit pack accordingly. If reconstitution is intended, add the liquid, final-volume basis and supporting in-use assessment to the development scope.

Translate the listed strength into a quantitative formula

Strength expressions in this entry include “3 gm”.

Tie every stated ingredient amount to its intended dosage unit or measure, then distinguish that declared amount from the quantity of raw material needed for a batch. Record any assay or equivalence calculation in the formula. This gives development, purchasing and artwork teams the same strength definition without assigning a patient dose from the catalogue.

Suggested starting point

A practical starting point is to translate the listed strength into a quantitative formula. For this powder brief, agree the target characteristics and a short set of measurable development questions before comparing prototypes or supplier proposals. Keep unresolved clinical claims outside the product specification until supporting evidence is available.

Discuss this product brief

Our clients

Trusted by companies building healthcare’s next generation.

Trusted manufacturing partner

Pharma, nutraceutical and fast-growing D2C companies choose Walter.

Manufacturing & packaging brief

Plan the powder presentation.

Use this preparation guide for Fosfomycin Trometamol 3 gm Powder. These are the decisions to resolve with the technical team before a site, process and commercial scope are confirmed.

Presentation & formulation

Clarify the intended route, composition per unit or measure and whether reconstitution is required. State the net fill weight and proposed use of the presentation in the technical brief.

Quality & technical transfer

Request review of the powder specification, analytical methods and applicable moisture, mixing and delivery requirements for the exact formulation.

Review the technical documents

Packaging configuration

Describe the sachet, pouch or container and any measuring accessory. Confirm required protection and compatibility against supporting stability information.

Explore packaging options

Details to confirm for this record

Exact presentation
Use “Fosfomycin Trometamol 3 gm Powder” consistently in the brief. Specify coating, release, grade or other presentation requirements explicitly where the catalogue does not define them.

Quantities, MOQ & lead time

For Fosfomycin Trometamol 3 gm Powder, state the pack count and net fill weight, target market and reorder forecast. MOQ and lead time depend on the assessed formula, process, components, testing and project readiness; request those terms in writing.

Discuss this manufacturing brief

Explore the context

Build the right manufacturing brief.

Common questions

Before you request a quotation.

Fosfomycin Trometamol 3 gm Powder

What is listed in the catalogue?

The catalogue lists Fosfomycin Trometamol 3 gm as powder in its anti-infectives navigation area and non-beta-lactam manufacturing stream.

How do you confirm manufacturing availability?

Send Walter your requirement for Fosfomycin Trometamol 3 gm Powder. The team reviews the applicable product permission and unit, formulation and equipment fit, testing, packaging and production schedule before confirming the manufacturing scope in writing. Request the relevant product and facility documents with your enquiry.

What do I need for a quotation?

Share the exact composition and strength, powder presentation, target market, initial quantity, preferred pack and timing. Identify whether this is a new product, development brief or transfer.

The quotation must confirm MOQ, inclusions, prerequisites and lead time for the proposed product and site.

What is needed for Indian and export markets?

For India, share the intended brand or institutional supply requirement, pack sizes, initial order quantity and artwork needs for Fosfomycin Trometamol 3 gm Powder. Confirm the applicable product permission, manufacturing unit and labelling requirements with the team.

For export, identify each destination country, proposed pack, language and registration or dossier requirements. Ask which product-specific quality and stability documents are available. Container compatibility and destination-market requirements need review; a catalogue record does not establish export registration or a shelf-life commitment.

How do I submit my enquiry?

Use the product-specific enquiry button to carry this composition and dosage form into the form. After a successful submission, a receipt reference confirms that your brief has been saved for review. Use the RFQ checklist to prepare the remaining details.

Technical document review

Which documents can I ask Walter to review?

Ask about manufacturing and packing records, specifications, analytical methods, Certificates of Analysis (COA), stability evidence, the Process Validation Protocol (PVP) and Process Validation Report (PVR). The wider checklist below covers supplier qualification, technical transfer and ongoing supply.

View the full document checklist 14 review areas
Site, licence and audit scope
Manufacturing licence, applicable product permissions, GMP certificates, Site Master File, supplier-qualification questionnaire and relevant audit responses.
Manufacturing, packing and batch release
Master Formula Record (MFR), master packing instructions, Batch Manufacturing Record (BMR), Batch Packing Record (BPR), reconciliation and authorised release records.
Process validation and continued verification
Process Validation Protocol (PVP), Process Validation Report (PVR), process performance qualification documents and continued process verification trends.
Equipment, facilities and utilities
Validation Master Plan (VMP), user requirements, DQ/IQ/OQ/PQ records, calibration and maintenance evidence for relevant equipment and utilities.
Cleaning, carryover and hold times
Cleaning Validation Protocol (CVP), Cleaning Validation Report (CVR), residue limits, recovery studies and applicable clean, dirty and process hold-time studies.
Specifications and analytical evidence
Specifications, Method of Analysis (MOA), Standard Testing Procedure (STP), Certificates of Analysis (COA), analytical validation, verification and method-transfer records.
Stability, packaging and transport
Stability protocols/reports, ongoing stability commitments, pack specifications, approved artwork, compatibility and applicable packaging or transport studies.
Development and technology transfer
Development report, technology-transfer protocol/report, gap assessment, control strategy, critical quality attributes and critical process parameters.
Quality reviews, investigations and changes
Product Quality Review (PQR) / Annual Product Review (APR), deviations, CAPA, change control, OOS/OOT trends, complaints, recalls and relevant SOP/training records.
Material suppliers and impurity risks
API/excipient supplier qualification, traceability, material COAs, relevant origin declarations and impurity risk assessments with supporting tests.
Sterile-product evidence, where applicable
Contamination Control Strategy (CCS), media-fill/aseptic simulation reports, sterilisation and filtration validation, environmental monitoring, sterility/endotoxin and container-closure integrity evidence.
Computerised systems and data integrity
Computerised-system validation, access controls, audit-trail review, backup/restore checks and relevant data-integrity procedures.
Market-specific regulatory support
Applicable dossier sections, API master-file/CEP support, bioequivalence or biowaiver evidence and Certificate of a Pharmaceutical Product (CPP/CoPP), where required and available.
Quality agreement and access arrangements
Quality/technical agreement covering responsibilities, release, changes, subcontracting, investigations, complaints, recalls, audits and document access.

Agree the list for the exact product, site, process, pack, market and project stage. QA confirms what exists, applies and may be shared; some records may require an NDA, redaction or controlled review. See document definitions and review guidance.

Important qualification

This B2B catalogue record is not proof of current approval or confirmation that Fosfomycin Trometamol 3 gm Powder is available for sale. It is not prescribing information or patient advice. Any Drugs Rules status, current approval, exemption, applicable unit, licence scope, formulation, claims, brand use, destination-market registration and commercial feasibility require documentary verification and Walter's written confirmation. Read the full regulatory disclaimer.

Composition and classification are taken from Walter's product catalogue. The manufacturing guide helps buyers prepare a technical brief. Clinical references, where shown, describe the cited product and study. Product page updated .

Quick chat on WhatsAppLet’s discuss your product